As the pandemic is in its final throes, we are beyond excited about the prospect of coming together in Vienna next spring for a live, in-person ECIO 2022!
Despite taking place online, ECIO 2021 offered a number of advantages. It reached a larger audience than ever and attracted a record number of physicians from neighbouring specialities who, through the Collaborating Cancer Initiative, were able to learn more about what their IR tumour board colleagues bring to the table.
The Scientific Programme Committee is already busy putting together a fantastic programme for ECIO 2022 which will cover everything there is to know about the fourth pillar of cancer care, ranging from established therapies to new applications, the latest in research and the newest tools and materials.
One of the key topics of ECIO 2022 will be immuno-oncology and how it can be further combined with minimally invasive procedures. Two clinical focus sessions will scrutinise where we currently are, review the available data and discuss where the field is headed. In addition, the possibilities offered by immuno-oncology will be featured in various sessions focussing on particular malignancies.
The importance of continuously revising the evidence base for what we do is further increasing. This is why a newly created Meet the PI session will provide an additional platform for some of the driving forces in current IO research who will present their studies’ design, methodology and preliminary results. We will hear about the Embocept study, ProActif, and the ABC study, among others. In addition, a clinical focus session will give young researchers a look at how to best conceptualise, set up and evaluate research and study projects.
The exchange of practical knowledge and experience will be another focus of our meeting, with renowned experts sharing their tips and tricks on a number of procedures, including lung and liver ablation, cryotherapy, and cementoplasty, just to name a few. In addition, a video learning session featuring various interesting cases will provide an excellent learning opportunity.
We have also increased the number of hands-on device trainings to ensure that all interventional oncologists wishing to practice on the latest devices will get a chance to do so. For interventional radiologists who are not yet familiar with minimally invasive oncological procedures, a day-long foundation course on the basics of IO will offer a fantastic opportunity to get started in this field.
Not to be missed, a high-profile multidisciplinary panel will discuss the impact of interventional oncology on the CRC tumour board. Similarly, state-of-the-art treatment for HCC will be debated by specialists from various medical fields. Another highlight will be the AI in IO session scrutinising the state of the art of artificial intelligence and its influence on our decision-making processes.
The MSK for advanced indications session promises to be another highlight, with experts shedding light on a variety of very noteworthy topics, such as implants-based vertebral augmentation, bona ablation with curative intent, and electrochemotherapy for spinal tumours. In a session dedicated to paediatric interventions, we will address another field of increasing importance in interventional oncology.
As you can see, there will be a wide array of fascinating topics. We invite all of you to browse the ECIO 2022 programme to find what best fits your interests and sparks your curiosity to widen your portfolio.
We look forward to seeing you all in Vienna!